Measurable residual disease in chronic lymphocytic leukemia. Where do we stand?
Ilaria Del Giudice1, Robin Foà2
1Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy. ilaria.delgiudice@uniroma1.it.
Leukemia
|October 14, 2023
Abstract
No abstract available in PubMed .
More Related Videos
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
11.1K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
